The Cochrane HIV/AIDS Group
The Cochrane Review Group on HIV/AIDS is one of 52 Collaborative Review Groups (CRGs) of the Cochrane Collaboration. Established in 1997, the Cochrane HIV/AIDS group brings together individuals from around the world who share an interest in writing, disseminating and updating systematic reviews of rigorous HIV/AIDS research. In a field evolving as rapidly as HIV and AIDS, the best evidence for treatment and prevention decisions may not always be clear. This is especially true in the developing world as well as outside the urban centers of the developed world. Cochrane systematic reviews on HIV/AIDS topics assist clinicians, public health practitioners, policy makers and consumers in making evidence-based decisions about HIV/AIDS prevention and treatment and provide direct translation of cutting-edge research into practice. For more information, please visit our Cochrane HIV/AIDS Group page.
The following are full Cochrane reviews in the areas of:
Reviews of Behavioral, Social and Policy Prevention
- Abstinence-only programs for HIV infection prevention in high-income countries
- Abstinence-plus programs for HIV infection prevention in high-income countries
- Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men
- Home-based HIV voluntary counseling and testing in developing countries
- Mass media interventions for promoting HIV testing
Reviews of Biomedical Prevention
- Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure
- Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals
- Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection
- Condom effectiveness in reducing heterosexual HIV transmission
- Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1
- Interventions for preventing late postnatal mother-to-child transmission of HIV
- Male circumcision for prevention of heterosexual acquisition of HIV in men
- Nonoxynol-9 for preventing vaginal acquisition of HIV infection by women from men
- Population-based interventions for reducing sexually transmitted infections, including HIV infection
- Vaginal disinfection for preventing mother-to-child transmission of HIV infection
- Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection
Reviews of Therapeutics, Prognostics and Diagnostics
- Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection
- Adjunctive therapies for AIDS dementia complex
- Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV
- Antimotility agents for chronic diarrhoea in people with HIV/AIDS
- Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy
- Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole
- Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV
- Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection
- Herbal medicines for treating HIV infection and AIDS
- Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults
- Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children
- Interventions for squamous cell carcinoma of the conjunctiva in HIV-infected individuals
- Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children
- Interventions for the treatment of decreased bone mineral density associated with HIV infection
- Interventions for treating AIDS-associated Hodgkin´s lymphoma in treatment-naive adults
- Iron supplementation for reducing morbidity and mortality in children with HIV
- Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings)
- Micronutrient supplementation in children and adults with HIV infection
- Nutritional interventions for reducing morbidity and mortality in people with HIV
- Prevention and treatment of cryptosporidiosis in immunocompromised patients
- Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults
- Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults
- Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults
- Three- or four- versus two-drug antiretroviral maintenance regimens for HIV infection
- Treatment for anemia in people with AIDS
- Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings
- Treatment of helminth co-infection in HIV-1 infected individuals in resource-limited settings
- Treatment of Kaposis sarcoma in HIV-1 infected individuals with emphasis on resource poor settings
- Treatment of latent tuberculosis infection in HIV infected persons
- Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults
Reviews of Health Services and Care
- Aerobic exercise interventions for adults living with HIV/AIDS
- Anabolic steroids for the treatment of weight loss in HIV-infected individuals
- Interventions for improving the psychosocial wellbeing of children affected by HIV/AIDS
- Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS
- Progressive resistive exercise interventions for adults living with HIV/AIDS
- Setting and organization of care for persons living with HIV/AIDS